Cancer stem cells revisited
- PMID: 28985214
- DOI: 10.1038/nm.4409
Cancer stem cells revisited
Abstract
The cancer stem cell (CSC) concept was proposed four decades ago, and states that tumor growth, analogous to the renewal of healthy tissues, is fueled by small numbers of dedicated stem cells. It has gradually become clear that many tumors harbor CSCs in dedicated niches, and yet their identification and eradication has not been as obvious as was initially hoped. Recently developed lineage-tracing and cell-ablation strategies have provided insights into CSC plasticity, quiescence, renewal, and therapeutic response. Here we discuss new developments in the CSC field in relationship to changing insights into how normal stem cells maintain healthy tissues. Expectations in the field have become more realistic, and now, the first successes of therapies based on the CSC concept are emerging.
Similar articles
-
Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.BMB Rep. 2017 Mar;50(3):117-125. doi: 10.5483/bmbrep.2017.50.3.222. BMB Rep. 2017. PMID: 27998397 Free PMC article. Review.
-
Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.Life Sci. 2019 Aug 15;231:116520. doi: 10.1016/j.lfs.2019.05.076. Epub 2019 May 31. Life Sci. 2019. PMID: 31158379 Review.
-
Cancer stem cell (CSC) resistance drivers.Life Sci. 2019 Oct 1;234:116781. doi: 10.1016/j.lfs.2019.116781. Epub 2019 Aug 17. Life Sci. 2019. PMID: 31430455 Review.
-
Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.Pharmacol Ther. 2022 Mar;231:107985. doi: 10.1016/j.pharmthera.2021.107985. Epub 2021 Sep 1. Pharmacol Ther. 2022. PMID: 34480963 Free PMC article. Review.
-
Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.J Cancer Res Clin Oncol. 2020 Jan;146(1):19-31. doi: 10.1007/s00432-019-03080-1. Epub 2019 Nov 16. J Cancer Res Clin Oncol. 2020. PMID: 31734836 Review.
Cited by
-
Crosstalk between Ca2+ Signaling and Cancer Stemness: The Link to Cisplatin Resistance.Int J Mol Sci. 2022 Sep 14;23(18):10687. doi: 10.3390/ijms231810687. Int J Mol Sci. 2022. PMID: 36142596 Free PMC article. Review.
-
The HEDGEHOG-GLI1 pathway is important for fibroproliferative properties in keloids and as a candidate therapeutic target.Commun Biol. 2023 Dec 7;6(1):1235. doi: 10.1038/s42003-023-05561-z. Commun Biol. 2023. PMID: 38062202 Free PMC article.
-
The "StemDif Sensor Test": A Straightforward, Non-Invasive Assay to Characterize the Secreted Stemness and/or Differentiation Activities of Tumor-Derived Cancer Cell Lines.Biomedicines. 2023 Dec 13;11(12):3293. doi: 10.3390/biomedicines11123293. Biomedicines. 2023. PMID: 38137514 Free PMC article.
-
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.Cancer Rep (Hoboken). 2021 Dec;4(6):e1417. doi: 10.1002/cnr2.1417. Epub 2021 Jun 7. Cancer Rep (Hoboken). 2021. PMID: 34101386 Free PMC article.
-
Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro.Int J Mol Sci. 2020 Jul 19;21(14):5100. doi: 10.3390/ijms21145100. Int J Mol Sci. 2020. PMID: 32707717 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources

